Brief: Abionyx Pharma Initiates Discussions With Iris Pharma For Possible Strategic Deal
Oct 11 (Reuters) - Abionyx Pharma SA ABNX.PA :
* ABIONYX PHARMA INITIATES DISCUSSIONS WITH IRIS PHARMA, A
WORLD
LEADER IN PRECLINICAL AND CLINICAL OPHTHALMOLOGY RESEARCH, WITH
A VIEW TO A POSSIBLE STRATEGIC DEAL
Source text for Eikon: ID:nBw1f3TDDa
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls